Raul E Ruiz-Lozano, Maria F Colorado-Zavala, Eugenia M Ramos-Dávila, Manuel E Quiroga-Garza, Nadim S Azar, Hazem M Mousa, Julio C Hernández-Camarena, Sandra S Stinnett, Melissa Daluvoy, Terry Kim, Maite Sainz-de-la-Maza, Russell P Hall, Alejandro Rodriguez-Garcia, Victor L Perez
PURPOSE: Analyze the influence of risk factors at presentation in the long-term immunosuppressive therapy (IMT) outcomes of ocular mucous membrane pemphigoid (OMMP). DESIGN: Retrospective multicenter study. PARTICIPANTS: OMMP patients seen at Duke Eye Center, Tecnologico de Monterrey, and Hospital Clinic of Barcelona from 1990-2022. METHODS: Data at presentation on demographics, direct immunofluorescence and ocular findings, extraocular sites of involvement (EOM) and prior treatments, in patients with a clinical and/or laboratory diagnosis of OMMP, were analyzed with multivariable analysis and Kaplan-Meier plots to identify factors associated with adverse outcomes...
March 5, 2024: Ophthalmology